Pharma Focus Asia

Virax Biolabs Introduces Real-Time PCR Test Kit

Wednesday, March 08, 2023

Virax Biolabs Group Limited announced that it has entered into an agreement for the distribution of an Avian Influenza A Virus ("AIV") real-time PCR test kit to markets accepting the CE mark, namely the European Union. The test kit is for the detection and differentiation of ribonucleic acid from AIV and the H5, H7 and H9 subtypes, including the H5N1 strain currently spreading in Europe.

The test kit is for use in laboratory settings and can help healthcare professionals accurately identify an AIV infection. It also serves as a valuable initial screening test for individuals exposed to AIV infected livestock or a high-risk environment.

With a real-time PCR tester ready to accurately and reliably detect AIV, including the deadly H5N1 strain, facilitating rapid and potentially life-saving interventions in particularly vulnerable jurisdictions.

Human infections with AIV have occurred in many countries, predominately after exposure to infected poultry or virus-contaminated environments. Six main haemagglutinin subtypes of bird flu viruses have infected people and have resulted in mild-to-severe illness with a wide range of symptoms and complications. These six subtypes include H3, H5, H6, H7, H9, and H10 viruses. Among these, H5N1 and H7N9 viruses have caused the majority of infections which occur in humans.

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024